Company intelligence / Profile preview

MEQU

Copenhagen, Denmark

Ownership: Private
Development stage: Other

Overview

The °M Warmer System is FDA-cleared to rapidly and reliably warm blood and IV fluids for trauma, emergency, and hospital use. Multiple trials with U.S. military and emergency medical services demonstrated the system’s ease of use, portability, and efficacy in preventing hypothermia in severely injured patients

Therapeutic areas: Hematology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Danish MilitaryTechnical University of Denmark (DTU)

Beyond the preview

Go deeper on MEQU.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MEQU.

Explore the full profile